The 28 day cycle of the final patient would have finished a month ago.
The safety committee's review would surely be ready very soon and that may indicate the conclusion of the dose-escalation stage,
Preliminary observations of efficacy in due course is what we really need to see.
I did attend the AGM and had a short chat with Dr Burns,
This is for general discussion only.
Ann: ACCENT Trial Recruitment Update, page-11
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $39.84M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $47.81K | 319.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161129 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |